Quarterly report · Q2

Period2023-09-01 → 2024-02-29
Filed2024-04-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 50
MetricValuePeriodScopeSource row
Revenue¥14.5bn2023-09-01 → 2024-02-29Cons.Net sales
Revenue¥25.6bn2022-09-01 → 2023-08-31Cons.Net sales (5-year summary)
Revenue¥12.4bn2022-09-01 → 2023-02-28Cons.Net sales
Operating income¥1.0bn2023-09-01 → 2024-02-29Cons.Operating income
Operating income¥678m2022-09-01 → 2023-02-28Cons.Operating income
Ordinary income¥1.1bn2023-09-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.1bn2023-09-01 → 2024-02-29Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.7bn2022-09-01 → 2023-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥708m2022-09-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥1.0bn2023-09-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥616m2022-09-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥642m2023-09-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.1bn2022-09-01 → 2023-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥414m2022-09-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥642m2023-09-01 → 2024-02-29Cons.Profit loss
Net income¥417m2022-09-01 → 2023-02-28Cons.Profit loss
Total assets¥44.3bnat 2024-02-29Cons.Assets
Total assets¥41.1bnat 2023-08-31Cons.Assets
Total assets¥39.0bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥30.7bnat 2024-02-29Cons.Liabilities
Total liabilities¥27.9bnat 2023-08-31Cons.Liabilities
Net assets / equity¥13.6bnat 2024-02-29Cons.Net assets
Net assets / equity¥13.2bnat 2023-08-31Cons.Net assets
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥10.3bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥11.2bnat 2023-08-31Cons.Cash and deposits
Cash & equivalents¥10.2bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥11.1bnat 2023-08-31Cons.Cash and cash equivalents
Cash & equivalents¥10.8bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2022-08-31dCons.Cash and cash equivalents
Operating cash flow−¥265m2023-09-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Operating cash flow¥865m2022-09-01 → 2023-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥397m2022-09-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.9bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥791m2022-09-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Financing cash flow¥708m2023-09-01 → 2024-02-29Cons.Net cash provided by used in financing activities
Financing cash flow¥1.9bn2022-09-01 → 2023-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥924m2022-09-01 → 2023-02-28Cons.Net cash provided by used in financing activities
EPS (basic)¥45.792023-09-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.992023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.512022-09-01 → 2023-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥29.462022-09-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.012022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥45.742023-09-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥78.462022-09-01 → 2023-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥29.452022-09-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio30.7%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio31.9%at 2023-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.3%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 45
SegmentItemPeriodValue
Otherother segmentsrevenue2023-09-01 → 2024-02-29¥1.0bn
Otherother segmentsrevenue external2023-09-01 → 2024-02-29¥1.0bn
Otherother segmentsrevenue intersegment2023-09-01 → 2024-02-29¥10m
Otherother segmentssegment profit2023-09-01 → 2024-02-29−¥167m
Reconciling Itemsreconcilingrevenue2023-09-01 → 2024-02-29−¥54m
Reconciling Itemsreconcilingrevenue intersegment2023-09-01 → 2024-02-29−¥54m
Reconciling Itemsreconcilingsegment profit2023-09-01 → 2024-02-29−¥335m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2023-09-01 → 2024-02-29¥2.6bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2023-09-01 → 2024-02-29¥2.6bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥2m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2023-09-01 → 2024-02-29¥41m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥5m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2023-09-01 → 2024-02-29−¥2m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2023-09-01 → 2024-02-29¥8.8bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2023-09-01 → 2024-02-29¥8.8bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥36m
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2023-09-01 → 2024-02-29¥1.4bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2023-09-01 → 2024-02-29¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2023-09-01 → 2024-02-29¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2023-09-01 → 2024-02-29¥86m
Total Of Reportable Segments And Otherssegment totalrevenue2023-09-01 → 2024-02-29¥14.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-09-01 → 2024-02-29¥14.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-09-01 → 2024-02-29¥54m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-09-01 → 2024-02-29¥1.4bn
Otherother segmentsrevenue2022-09-01 → 2023-02-28¥540m
Otherother segmentsrevenue external2022-09-01 → 2023-02-28¥540m
Otherother segmentssegment profit2022-09-01 → 2023-02-28−¥2m
Reconciling Itemsreconcilingsegment profit2022-09-01 → 2023-02-28−¥255m
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥2.8bn
jpcrp040300-q2r_E01064-000Department Store Businessreportable segmentsegment profit2022-09-01 → 2023-02-28¥13m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentrevenue external2022-09-01 → 2023-02-28¥698m
jpcrp040300-q2r_E01064-000Food Service Businessreportable segmentsegment profit2022-09-01 → 2023-02-28−¥121m
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentrevenue external2022-09-01 → 2023-02-28¥7.3bn
jpcrp040300-q2r_E01064-000Health Carereportable segmentsegment profit2022-09-01 → 2023-02-28¥940m
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentrevenue external2022-09-01 → 2023-02-28¥1.1bn
jpcrp040300-q2r_E01064-000Medical Productsreportable segmentsegment profit2022-09-01 → 2023-02-28¥103m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2023-02-28¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2023-02-28¥933m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Transactions with other segmentsPrior1YTDDuration_OtherReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember7326508000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember1064101000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember2816517000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember697983000JPY
Net salesPrior1YTDDuration_OtherReportableSegmentsMember539688000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember12444800000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-JPY
Net salesPrior1YTDDuration12444800000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember940267000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember103468000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember12788000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember-121317000JPY
Operating incomePrior1YTDDuration_OtherReportableSegmentsMember-1997000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember933209000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-254914000JPY
Operating incomePrior1YTDDuration678295000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember8785847000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember1083112000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember2640180000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember1032381000JPY
Revenues from external customersCurrentYTDDuration_OtherReportableSegmentsMember1001459000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember14542980000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration14542980000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember36282000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember-JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember1701000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember5400000JPY
Transactions with other segmentsCurrentYTDDuration_OtherReportableSegmentsMember10242000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember53626000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-53626000JPY
Transactions with other segmentsCurrentYTDDuration-JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember8822129000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember1083112000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember2641882000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember1037782000JPY
Net salesCurrentYTDDuration_OtherReportableSegmentsMember1011701000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember14596607000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-53626000JPY
Net salesCurrentYTDDuration14542980000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember1400009000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember86341000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember40705000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember-2090000JPY
Operating incomeCurrentYTDDuration_OtherReportableSegmentsMember-166748000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1358218000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-08-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-08-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-09-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2022-09-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2023-09-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-09-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-09-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-08-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass